Literature DB >> 12359424

A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions.

Martha Simpson-Holley1, Darren Ellis, Dawn Fisher, Debra Elton, John McCauley, Paul Digard.   

Abstract

Morphogenesis of influenza virus is a poorly understood process that produces two types of enveloped virion: approximately 100-nm spheres and similar diameter filaments that reach 20 microm in length. Spherical particles assemble at plasma membrane lipid rafts in a process independent of microfilaments. The budding site of filamentous virions is hitherto uncharacterised but their formation involves the actin cytoskeleton. We confirm microfilament involvement in filamentous budding and show that after disruption of cortical actin by jasplakinolide, HA, NP, and M1 redistributed around beta-actin clusters to form novel annular membrane structures. HA in filamentous virions and jasplakinolide-induced annuli was detergent insoluble at 4 degrees C. Furthermore, in both cases HA partitioned into low buoyant density detergent-insoluble glycolipid domains, indicating that filamentous virions and annuli contain reorganised lipid rafts. We propose that the actin cytoskeleton is required to maintain the correct organisation of lipid rafts for incorporation into budding viral filaments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359424     DOI: 10.1006/viro.2002.1595

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  61 in total

1.  Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.

Authors:  Kevin M Coombs; Alicia Berard; Wanhong Xu; Oleg Krokhin; Xiaobo Meng; John P Cortens; Darwyn Kobasa; John Wilkins; Earl G Brown
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

2.  Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT.

Authors:  Tatiana Fislová; Benjamin Thomas; Katy M Graef; Ervin Fodor
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

3.  Intrinsic cytoskeleton-dependent clustering of influenza virus M2 protein with hemagglutinin assessed by FLIM-FRET.

Authors:  Bastian Thaa; Andreas Herrmann; Michael Veit
Journal:  J Virol       Date:  2010-09-29       Impact factor: 5.103

Review 4.  Plasmodesmata viewed as specialised membrane adhesion sites.

Authors:  Jens Tilsner; Khalid Amari; Lesley Torrance
Journal:  Protoplasma       Date:  2010-10-12       Impact factor: 3.356

5.  Shape effects of filaments versus spherical particles in flow and drug delivery.

Authors:  Yan Geng; Paul Dalhaimer; Shenshen Cai; Richard Tsai; Manorama Tewari; Tamara Minko; Dennis E Discher
Journal:  Nat Nanotechnol       Date:  2007-03-25       Impact factor: 39.213

6.  Simultaneous multicolor imaging of biological structures with fluorescence photoactivation localization microscopy.

Authors:  Nikki M Curthoys; Michael J Mlodzianoski; Dahan Kim; Samuel T Hess
Journal:  J Vis Exp       Date:  2013-12-09       Impact factor: 1.355

7.  Actin mediates the nanoscale membrane organization of the clustered membrane protein influenza hemagglutinin.

Authors:  Manasa V Gudheti; Nikki M Curthoys; Travis J Gould; Dahan Kim; Mudalige S Gunewardene; Kristin A Gabor; Julie A Gosse; Carol H Kim; Joshua Zimmerberg; Samuel T Hess
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

8.  The Rab11 pathway is required for influenza A virus budding and filament formation.

Authors:  Emily A Bruce; Paul Digard; Amanda D Stuart
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

9.  Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus.

Authors:  Masaki Imai; Kazunori Kawasaki; Takato Odagiri
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

Review 10.  Viral exploitation of actin: force-generation and scaffolding functions in viral infection.

Authors:  Mark Spear; Yuntao Wu
Journal:  Virol Sin       Date:  2014-06-06       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.